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Aims 
   Pathological response to neo-adjuvant chemotherapy (NAC) in the primary tumour is 
associated with improved survival outcomes in resected oesophageal adenocarcinoma 
(OAC).  A sub-group of patients do not demonstrate response in their primary tumours but 
do obtain benefit from the downstaging of their nodal disease.  We sought to assess the 
prognostic ability of tumoural response and downstaging of the primary tumour or lymph 
nodes.   
Methods 
   Clinical and pathological staging data was collected for 172 patients treated with 
cisplatin-based NAC followed by surgical resection at a single institution between 2004 
and 2012.   Response to chemotherapy was defined according to the Mandard Tumour 
Regression Grade (TRG).  Tumour (T) and lymph node (LN) stage was assessed at 
diagnosis radiologically (computed tomography, endoscopic ultrasonography(EUS) 
positron emission tomography) and then pathologically at resection.  A decrease of more 
than 1 in T or N stage following chemotherapy was defined as tumour and lymph node 
downstaging respectively. 
Results 
   A Mandard Score was available for 159 cases and a response to NAC (TRG 1/2) was 
apparent in 18 (10.5%) tumours and no response (TRG 3/4/5) in 141 (88.7%) tumours. 
TRG 1/2 was associated with an improved relapse-free (HR 0.33, 95% CI 0.18-0.59; 
p<0.001) and overall survival (HR 0.36, 95% CI 0.2-0.65; p<0.001).  Accurate pre-
treatment assessment of T and LN stage was available in 156 and 144 cases 
respectively.  T downstaging occurred in 44 (28.2%) cases and was associated with 
improved relapse-free (HR 0.43, 95% CI 0.28-0.70; p<0.001) and overall survival (HR 
0.45, 95% CI 0.29-0.70; p<0.001).  L downstaging occurred in 40 (27.8%) of cases and 
was associated with improved relapse-free (HR 0.54, 95% CI 0.33-0.89; p=0.014) and 
overall survival (HR 0.47, 95% CI 0.29-0.75; p=0.002).      
Conclusions  
   Response to NAC in the primary tumour and in the lymph nodes are both associated 
with improved survival outcomes in OAC. 
